Lexaria Bioscience appoints Michael Shankman as CFO

Lexaria Bioscience announces the appointment of Michael Shankman, CPA, as CFO effective immediately. As a member of the executive leadership team, Mr. Shankman will lead the Company’s financial operations. Shankman has previously worked with Lexaria and assisted with its financial reporting and 2023 audit as a designated contractor and as such is deeply familiar with the Company. From 2021 to 2024 Mr. Shankman provided outsourced CFO and Controller services for a national service provider, gaining extensive experience and familiarity with both public and private companies in a wide variety of industry fields.